Intratracheal budesonide improves survival in preterm infants with bronchopulmonary dysplasia: Study
A recent clinical trial published in the Journal of American Medical Association found the potential of early intratracheal ...
In extremely preterm infants receiving surfactant, early intratracheal budesonide had little to no effect on survival free of bronchopulmonary dysplasia (BPD), a randomized clinical trial found.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback